Use of Statins and Risk of Hospitalization With Dementia A Danish Population-based Case-control Study

被引:19
作者
Horsdal, Henriette Thisted [1 ,3 ]
Olesen, Anne Vingard [2 ,4 ]
Gasse, Christiane [1 ,5 ]
Sorensen, Henrik Toft [1 ,6 ,7 ,8 ,9 ,10 ,11 ]
Green, Robert C. [6 ,7 ,8 ,9 ,10 ,11 ]
Johnsen, Soren Paaske [1 ]
机构
[1] Univ Aarhus, Dept Clin Epidemiol, Aarhus, Denmark
[2] Univ Aarhus, Aalborg Psychiat Hosp, Unit Psychiat Res, Aarhus, Denmark
[3] Univ Aarhus, Dept Pharmacol, Aarhus, Denmark
[4] Univ Aarhus, Dept Epidemiol, Inst Publ Hlth, Aarhus, Denmark
[5] Univ Aarhus, Natl Ctr Registry Based Res, Aarhus, Denmark
[6] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[7] Boston Univ, Sch Med, Dept Med Genet, Boston, MA 02118 USA
[8] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA
[9] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA
[10] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA 02118 USA
[11] Boston Univ, Sch Publ Hlth, Dept Med Genet, Boston, MA 02118 USA
关键词
statins; dementia; risk; epidemiology; case-control study; LIPID-LOWERING AGENTS; NITRIC-OXIDE SYNTHASE; ALZHEIMER-DISEASE; REDUCTASE INHIBITORS; INCIDENT DEMENTIA; CONTROLLED TRIAL; HEALTH; SIMVASTATIN; PRAVASTATIN; PREVENTION;
D O I
10.1097/WAD.0b013e318180f55b
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several epidemiologic studies have indicated reduced risk of dementia among users of statins. We assessed the risk of hospitalization with dementia associated with use of statins in a population-based case-control study in 4 Northern Danish counties in the period 1991 to 2005. We identified 11,039 cases with dementia and 110,340 age- matched and sex-matched population controls using data from the National Patient Registry, the Danish Psychiatric Central Register, and the Civil Registration System. Prescriptions for statins filled before the admission for dementia were identified using population-based prescription databases. We used conditional logistic regression analysis to compute relative risk of hospitalization with dementia associated with use of statins using nonusers as reference group. We found an overall reduced risk of hospitalization with dementia among statin users (adjusted odds ratio: 0.67, 95% confidence intervals: 0.60-0.75). The reduce risk associated with statin use remained robust in various subanalyses, however, we found no clear dose-response pattern between the number of filled prescriptions for statin and the risk of hospitalization with dementia. In conclusion, we found a reduced risk of hospitalization with dementia among users of statins, however, whether this association is causal remains to be clarified.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 42 条
[1]  
Andersen TF, 1999, DAN MED BULL, V46, P263
[2]   Social position and health in old age: the relevance of different indicators of social position [J].
Avlund, K ;
Holstein, BE ;
Osler, M ;
Damsgaard, MT ;
Holm-Pedersen, P ;
Rasmussen, NK .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2003, 31 (02) :126-136
[3]   Treating nondementia illnesses in patients with dementia [J].
Brauner, DJ ;
Muir, JC ;
Sachs, GA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24) :3230-3235
[4]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[5]   Statins in the prevention and treatment of Alzheimer disease [J].
Crisby, M ;
Carlson, LA ;
Winblad, B .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (03) :131-136
[6]   Alzheimer disease as a vascular disorder - Nosological evidence [J].
de la Torre, JC .
STROKE, 2002, 33 (04) :1152-1162
[7]   APOE genotype, cholesterol level, lipid-lowering treatment, and dementia -: The Three-City Study [J].
Dufouil, C ;
Richard, F ;
Fiévet, N ;
Dartigues, JF ;
Ritchie, K ;
Tzourio, C ;
Amouyel, P ;
Alpérovitch, A .
NEUROLOGY, 2005, 64 (09) :1531-1538
[8]   Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J].
Endres, M ;
Laufs, U ;
Huang, ZH ;
Nakamura, T ;
Huang, P ;
Moskowitz, MA ;
Liao, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8880-8885
[9]   Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo [J].
Fassbender, K ;
Simons, M ;
Bergmann, C ;
Stroick, M ;
Lütjohann, D ;
Keller, P ;
Runz, H ;
Kühl, S ;
Bertsch, T ;
von Bergmannn, K ;
Hennerici, M ;
Beyreuther, K ;
Hartmann, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5856-5861
[10]  
Gaist D, 1997, DAN MED BULL, V44, P445